2023年10月以色列特拉维夫区部分接种儿童中与学前机构相关的麻疹暴发
2023年10月特拉维夫区报告10例麻疹,暴发始于一名单剂MMR疫苗高接种率的学前机构。8例患者(6名儿童、2名成人)接受血清学检测,6名接种1剂MMR的儿童证实原发性疫苗失败,成人证实继发性疫苗失败。通过密切接触者及全区儿童2剂MMR接种等预防措施成功控制暴发。
要点
- 2023年10月特拉维夫区报告10例麻疹,暴发始于单剂MMR高接种率的学前机构。
- 6名接种1剂MMR的儿童证实原发性疫苗失败,2名成人证实继发性疫苗失败。
- 对密切接触者和特拉维夫区儿童实施2剂MMR接种等预防措施成功控制暴发。
核心结论
- 尽管处于战争时期,及时执行包括2剂MMR接种在内的预防措施成功遏制了暴发并防止了广泛传播。
研究设计与样本
- 2023年10月特拉维夫区报告10例麻疹病例的暴发调查。
- 对8例患者(6名儿童和2名成人)进行血清学检测。
主要发现
- 暴发始于单剂MMR疫苗高接种率的学前机构。
- 6名接种1剂MMR的儿童证实原发性疫苗失败。
- 2名成人证实继发性疫苗失败。
- 暴发得以成功遏制,因素包括特拉维夫高疫苗接种覆盖率人群及战时公共互动受限。
关键数值与推荐
- 对密切接触者和特拉维夫区更广泛儿童社区采用2剂MMR疫苗接种方案。
临床怎么用
- 对密切接触者和特拉维夫区儿童实施2剂MMR疫苗接种方案的预防措施。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In October 2023, the Tel Aviv District was notified of ten cases of measles. The outbreak initiated in a preschool with high vaccination coverage with one dose of MMR vaccine. Serological testing was available for eight patients (six children and two adults). Among the six children vaccinated with one dose of MMR vaccine, primary vaccine failure was demonstrated. Among the adults, secondary vaccine failure was confirmed. The outbreak was successfully contained due to a combination of factors, notably its occurrence within a population characterized by high vaccination coverage in Tel Aviv, during a period of restricted public interactions due to the prevailing state of war in the country. Despite challenging wartime conditions, effective prophylactic measures were promptly executed, encompassing a 2-dose MMR vaccination schedule for close contacts and the broader community of children in the TA district, successfully curbing the outbreak and preventing widespread infections.
引用
- Sheffer R, Bucris E, Amitai Z, et al. Measles outbreak associated with a preschool setting among partially vaccinated children in the Tel Aviv District, Israel, October 2023. Vaccine. 2024. PMID: 38627149. doi:10.1016/j.vaccine.2024.04.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。